Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tvardi Therapeutics (TVRD) Receivables Refunds (2016 - 2024)

Tvardi Therapeutics' Receivables Refunds history spans 12 years, with the latest figure at $697000.0 for Q2 2024.

  • On a quarterly basis, Receivables Refunds changed 0.0% to $697000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $697000.0, a 0.0% change, with the full-year FY2023 number at $697000.0, changed 0.0% from a year prior.
  • Receivables Refunds hit $697000.0 in Q2 2024 for Tvardi Therapeutics, roughly flat from $697000.0 in the prior quarter.
  • Over the last five years, Receivables Refunds for TVRD hit a ceiling of $1.5 million in Q4 2020 and a floor of $697000.0 in Q2 2021.
  • Historically, Receivables Refunds has averaged $854722.2 across 5 years, with a median of $697000.0 in 2021.
  • Biggest five-year swings in Receivables Refunds: surged 84.68% in 2020 and later crashed 53.75% in 2021.
  • Tracing TVRD's Receivables Refunds over 5 years: stood at $1.5 million in 2020, then crashed by 53.75% to $697000.0 in 2021, then changed by 0.0% to $697000.0 in 2022, then changed by 0.0% to $697000.0 in 2023, then changed by 0.0% to $697000.0 in 2024.
  • Business Quant data shows Receivables Refunds for TVRD at $697000.0 in Q2 2024, $697000.0 in Q1 2024, and $697000.0 in Q4 2023.